Tyra Biosciences (TYRA) Accumulated Depreciation & Amortization (2020 - 2025)
Quarterly Accumulated Depreciation & Amortization rose 50.43% to $1.4 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Mar 2025, up 50.43% year-over-year, with the annual reading at $1.3 million for FY2024, 58.74% up from the prior year.
Tyra Biosciences filings provide 6 years of Accumulated Depreciation & Amortization readings, the most recent being $1.4 million for Q1 2025.
- Accumulated Depreciation & Amortization hit $1.4 million in Q1 2025 for Tyra Biosciences, up from $1.3 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $1.4 million in Q1 2025 and bottomed at $119000.0 in Q3 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $678466.7, with a median of $629000.0 recorded in 2023.
- The largest annual shift saw Accumulated Depreciation & Amortization skyrocketed 293.02% in 2021 before it surged 50.43% in 2025.
- Tyra Biosciences' Accumulated Depreciation & Amortization stood at $169000.0 in 2021, then soared by 172.78% to $461000.0 in 2022, then surged by 75.05% to $807000.0 in 2023, then skyrocketed by 58.74% to $1.3 million in 2024, then rose by 8.74% to $1.4 million in 2025.
- Per Business Quant, the three most recent readings for TYRA's Accumulated Depreciation & Amortization are $1.4 million (Q1 2025), $1.3 million (Q4 2024), and $1.2 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 926,000.00 |
| Mar 31, 2024 | 926,000.00 |
| Dec 31, 2023 | 807,000.00 |
| Dec 31, 2023 | 807,000.00 |
| Sep 30, 2023 | 706,000.00 |
| Sep 30, 2023 | 706,000.00 |
| Jun 30, 2023 | 629,000.00 |
| Jun 30, 2023 | 629,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 233,000.00 |
| Mar 31, 2022 | 233,000.00 |
| Dec 31, 2021 | 169,000.00 |
| Dec 31, 2021 | 169,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Dec 31, 2020 | 43,000.00 |
| Dec 31, 2020 | 43,000.00 |